Home › Targets › EGFR
EGFR (4 companies · 10 programs)
Companies with an active program directed at EGFR.
- ficerafusp alfa — Head and Neck Squamous Cell Carcinoma Phase 3
- ficerafusp alfa — Colorectal Cancer Phase 1
- ficerafusp alfa — Cutaneous Squamous Cell Carcinoma Phase 1
- ficerafusp alfa — Anal Squamous Cell Carcinoma Phase 1
- VIR-5525 — Non-Small Cell Lung Cancer Phase 1
- VIR-5525 — Colorectal Cancer Phase 1
- VIR-5525 — Head and Neck Squamous Cell Carcinoma Phase 1
- VIR-5525 — Cutaneous Squamous Cell Carcinoma Phase 1
- zipalertinib — Non-Small Cell Lung Cancer NDA Submitted
